SLNO

Soleno Therapeutics
SLNO

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$3.31B
EV
$3.05B
Shares Outstanding
51.78M
Beta
-2.29

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$108.63
P/E 2025E
-
P/Revenue 2025E
83.33x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Soleno Therapeutics, Inc.

gainify
SLNO

Soleno Therapeutics, Inc.

SLNO

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet...

Sector

Healthcare

Industry

Biotechnology

CEO

Bhatnagar, Anish

Employees

92

IPO Date

2014-11-13

Headquarters

203 Redwood Shores Parkway, Suite 500, Redwood City, California, 94065, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved